MENU
JPMA
  • Access
  • Japanese
  • About JPMA

    About JPMA Top

    • Message from the President
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • About Pharmaceuticals

    About Pharmaceuticals Top

    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee

    Information from the Committee Top

    • Code Compliance Committee
    • Pharmaceutical Industrial Policy Committee
    • Distribution Improvement Committee
    • Drug Evaluation Committee
    • Quality & Technology Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • R&D Committee
    • International Affairs Committee
    • Public Affairs Committee
    • Patient Cooperation Committee
    • ICH Project
    • APAC Project
    • Consumer Consultation Review Committee
    • Environmental Issue Committee
  • Newsletter
  • News Room

    Newsroom Top

    • News Releases and Announcements
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video content and advertisements
  • The Office of Pharmaceutical Industry Research
Close
JPMA

Return to Site Top

  • For Patients and the Public (About Pharmaceuticals)
    For Patients and the Public (Pharmaceuticals) Top
    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee
    Information from the Committee Top
    • Code Compliance Committee
    • Pharmaceutical Industrial Policy Committee
    • Distribution Improvement Committee
    • Drug Evaluation Committee
    • Quality & Technology Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • R&D Committee
    • International Affairs Committee
    • Public Affairs Committee
    • Patient Cooperation Committee
    • ICH Project
    • APAC Project
    • Consumer Consultation Review Committee
    • Environmental Issue Committee
  • About JPMA
    About JPMA Top
    • Message from the President
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • Policies and Activities
    Policies and Activities Top
    • Business Policy, Business Plan, and Implementation Plan
    • Committee Activities
    • Convention on Biological Diversity
  • Voluntary Standards
    Voluntary Standards Top
    • Charter of Conduct
    • JPMA Code of Practice
    • Transparency Guideline for the Relation between Corporate Activities and Medical Institutions
    • Transparency Guideline for Relationships between Corporate Activities and Patient Groups
    • Guidelines for the Preparation of Product Information Summaries for Ethical Drugs (Abbreviated name: Preparation Guidelines)
    • Clinical Research
    • Basic Philosophy and Action Guidelines on Biodiversity
    • Guidelines Concerning Appropriate Competition in Japan Pharmaceutical Manufacturers Association Meetings
    • Guidelines for the Promotion of Pharmaceutical Industry in Japan
  • News Room
    Newsroom Top
    • News Releases and Announcements
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video content and advertisements
  • The Office of Pharmaceutical Industry Research  Page will open in a new window.
  • Social Media Policy
  • Website Terms of Use
  • Access
  • Japanese
  • Top
  • Information from the Committee
  • Code Compliance Committee
  • Announcement from Code Compliance Committee
  • Year 2025

Year 2025

  • Year 2026
  • Year 2025
  • Year 2024
  • Year 2023
  • Year 2022
  • October 16, 2025

    JPMA Code of Practice "Code Understanding Promotion Month

  • Oct 01, 2025

    JPMA Code of Practice (Revised May 2025)" Book Issued

  • Sep 17, 2025

    Meeting of Code Administration Managers and Practitioners for 2025

  • Sep 11, 2025

    The article of Nikkan Yakugyo interview with Chairperson of Review Board of Ethical Drug Product Information Brochure, Mr. Kondo, was published in Nikkan Yakugyo.

    Chairperson Kondo, Review Board of Ethical Drug Product Information Brochure, plans training sessions with medical personnel to develop human resources.
  • Sep 08, 2025

    The article by Chairperson Ouchi of the Code Compliance Promotion Committee was published in the "Nikkan Yakugyo" section of the "Toward the Age of Co-Creation" <7>.

    Revised COP, "Focus on penetration of philosophy," Ouchi, Chairperson of the Code and Compliance Promotion Committee
  • Aug 22, 2025

    Transparency Guideline for the Relation between Corporate Activities and Medical Institutions has been updated.

  • Jul 31, 2025

    JPMA Newsletter No.226 introduced "Code Compliance Committee".

  • May 23, 2025

    JPMA Code of Practice" was revised.

  • Apr 10, 2025

    Meeting of Compliance Managers and Practitioners for FY2024" was held.

  • Mar 25, 2025

    Workshop for Persons Responsible for Product Information Overview Management and Practice Managers in 2024" was held

  • Year 2026
  • Year 2025
  • Year 2024
  • Year 2023
  • Year 2022

Share this page

  • Tweet
  • Share this page

TOP

Site Search

  • Top
  • Information from the Committee
  • Code Compliance Committee
  • Announcement from Code Compliance Committee
  • Year 2025
  • JPMA PR and Communication Activities
  • Pharmaceutical Research Institute
  • List of Non-Financial Information Disclosure by Member Companies
  • STOP AMR
  • About JPMA
  • Policies and Activities
  • Voluntary Standards
  • Global Health
  • News Room
  • For Patients and the Public (About Pharmaceuticals)
  • Clinical Trials Information
  • Information from the Committee
  • JapanesePage will open in a new window.
  • x
  •  facebook
  •  youtube
  • Site Map
  • Website Terms of Use
  • Privacy Policy
  • Social Media Policy
  • Linking Policy
  • Accessibility Policy
  • PRAISE-NET Login

© Japan Pharmaceutical Manufacturers
Association(JPMA).

Notification

This website uses automatic translation.
The translated content may not always be fully consistent with the original Japanese content.